Mitigation

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Retrieved on: 
Thursday, May 11, 2023
MDMC, REMS, MDAI, Depression, Therapy, MDEA, Mitigation, Methylone, Anxiety, Therapeutic index, Pathology, Pharmacokinetics, PCT, MDE, DSM-IV codes, Literature, OF, Patent, Patient, Post-traumatic stress disorder, USE, MBDB, Empathy, Salt, SALTS, MDMA, Safety, Pharmaceutical industry, Vaccine, Terran, PTSD

The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.

Key Points: 
  • The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.
  • Terran believes that therapeutic options for patients should be equally diverse, with unique psychedelics and empathogens tailored to specific patient needs.
  • Terran completed what is believed to be the first comprehensive salt and polymorph screen performed to date on this compound.
  • Terran completed additional improvements including the synthesis of deuterated forms of racemic methylone, R-methylone, and S-methylone with improved pharmacokinetics.

Seeing conservation solutions for unseen species

Retrieved on: 
Wednesday, May 10, 2023
Knowledge, Great Plains toad, Learning, ATK, Food, Cree, Breeding, Tree, Nakoda, Committee on the Status of Endangered Wildlife in Canada, Endangered species, Wind, Timber rattlesnake, Committee, California species of special concern, Eastern red bat, Tiger salamander, Frost, Pesticide, Hawaiian hoary bat, Climate change, Animal, Nature, Fern, Water, Gekkoninae, Mortality, COSEWIC, Mitigation, News, Hunting

COSEWIC, the Committee on the Status of Endangered Wildlife in Canada, met last week to consider the status of 16 wildlife species.

Key Points: 
  • COSEWIC, the Committee on the Status of Endangered Wildlife in Canada, met last week to consider the status of 16 wildlife species.
  • These included several that go unseen – those that are active in the night or that live underground or in hard-to-reach places.
  • Assessing secretive species underscores the importance of looking a little closer and learning all that we can to help them survive.
  • Several of the assessed species are not just hard to see but have actually gone unseen for decades.

DataDome Expands Partner Program to Accelerate Delivery of Best-in-Class Protection to Enterprises Worldwide

Retrieved on: 
Wednesday, May 10, 2023
Cloud, Ermete Realacci, DNA, Disbursement Acceleration Program, Tier 1, Google Cloud Platform, Great Places, Azure, ISV, Mitigation, Forrester, AWS, Online shopping, G2

NEW YORK, May 10, 2023 /PRNewswire/ -- DataDome, a leading provider of AI-powered online fraud and bot management, is proud to announce it is strategically expanding its channel presence with the hire of Teague Dufresne, Director of Channel Sales, and a streamlined partner program that will support the evolving needs of today's enterprises in the fight against online fraud and automated threats.

Key Points: 
  • "I am thrilled to develop a partner program for a solution that has seen such great adoption globally," said Teague Dufresne, Director of Channel Sales at DataDome.
  • DataDome already touts a robust technical and business partner ecosystem , and recently joined  the AWS Independent Software Vendor (ISV) Accelerate Program .
  • "Customer centricity is at the core of DataDome's DNA," said Aurelie Guerrieri, Chief Marketing & Alliances Officer at DataDome.
  • By expanding our partner program, we are bringing this simplicity to our partners' customers, arming them with the protection necessary to stop fraudsters in their tracks."

Asia-Pacific Medical Imaging Equipment and Informatics Outlook 2023: An Influx of Startups will Prompt Established Market Leaders to Explore Strategic Partnerships or Acquisitions

Retrieved on: 
Wednesday, May 10, 2023
Mitigation, Medical imaging, Radiology

Disparate Data Source Volumes will Reach New Highs, Providing a Strong Opportunity to Mitigate Interoperability Issues in Radiology Workflows

Key Points: 

Disparate Data Source Volumes will Reach New Highs, Providing a Strong Opportunity to Mitigate Interoperability Issues in Radiology Workflows

Fractyl Health to Present Preclinical Proof-of-Concept Data for Rejuva® Pancreatic Gene Therapy Platform Program at the American Society of Gene & Cell Therapy Congress

Retrieved on: 
Tuesday, May 9, 2023
Biotechnology, Diabetes, Health, Finance, Healthcare Reform, Public Policy, Government, Professional Services, Other Science, Research, Public Relations, Investor Relations, General Health, Communications, Science, Clinical Trials, Toxicity, Obesity, Therapy, Gene, Mitigation, Type 2 diabetes, Safety, Pancreas, Liver, PDT, DDW, Metabolism, Congress, Cell, T2D, Society, Treatment, Pharmaceutical industry, Vitro

This presentation will provide new preclinical proof-of-concept efficacy data of Fractyl Health's pancreatic gene therapy delivery platform with GLP-1 receptor analog-based gene therapy for T2D and obesity.

Key Points: 
  • This presentation will provide new preclinical proof-of-concept efficacy data of Fractyl Health's pancreatic gene therapy delivery platform with GLP-1 receptor analog-based gene therapy for T2D and obesity.
  • At Keystone Symposium, Fractyl Health presented data on progress identifying optimized, islet-targeted gene therapy candidates capable of improving pancreatic beta cell function in vitro and in preclinical models with localized GLP1-based gene therapy in the pancreas.
  • "We are enthusiastic about sharing our latest findings and advancements in the field of pancreatic gene therapy at the upcoming ASGCT Congress," said Dr. Harith Rajagopalan, CEO of Fractyl Health.
  • Progress on our Rejuva program shows that we are committed to developing innovative solutions for T2D while carefully addressing potential safety concerns in gene therapy applications."

MeriTalk Names 2023 Cyber Defenders Award Winners

Retrieved on: 
Monday, May 8, 2023
Technology, Mobile, Wireless, Security, Public Policy, Government, Software, Networks, White House, Federal Government, Hardware, Smoke, Telecommunications, General Services Administration, Public sector, Defense Innovation Unit, Information security, General Dynamics, Endpoint, Defense, Federal Engineer of the Year Award, Federal Office for Information Security, Forest Law Enforcement and Governance Program, United States Department of Homeland Security, Cybersecurity and Infrastructure Security Agency, Information technology, Information Systems Security Association, TIC, Intel, Assistant, Information, Technical, Information system, Entrepreneurship, Executive Office of the President of the Republic of Indonesia, Research, Mitigation, United States Department of Veterans Affairs, Department of Defence, Defense Information Systems Agency, Arms industry, Risk management, Medical device, Management, Computer security

Today, MeriTalk announced the winners of the 2023 Cyber Defenders Awards.

Key Points: 
  • Today, MeriTalk announced the winners of the 2023 Cyber Defenders Awards.
  • The awards recognize individuals in government and industry who drive innovation, advance our nation’s cybersecurity, and who have made significant contributions across cyber programs in Federal IT.
  • “These leaders are advancing security initiatives impacting our government – and our nation’s – cybersecurity,” said Caroline Boyd, principal, government programs at MeriTalk.
  • “We’re pleased to be able to recognize their innovation, commitment, and outstanding achievements.”
    This year’s winners are listed below.

Xtalks Announces its Life Science Webinar Calendar for May 2023

Retrieved on: 
Friday, May 5, 2023
Steps, Wearable computer, Alzheimer's disease, Partner, NGS, Personalized medicine, Evolution, Automation, CNS, Depression, Assistant Secretary for Health, Drug discovery, Patient, Liquid biopsy, Mitigation, ChromeOS, Pharmaceutical industry, Fine chemical, Birth control, Medical imaging, Medical device, WHO model list of essential in vitro diagnostics, Xtalk

TORONTO, May 5, 2023 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Key Points: 
  • Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, commercialization & HEOR, drug discovery & development, laboratory technology, patient recruitment & retention, pharmaceutical, pharmaceutical regulation, pharmaceutical manufacturing & supply chain and preclinical.
  • TORONTO, May 5, 2023 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries.
  • Access to all webinars is free, so be sure to register today to save your place!
  • Participate in the discussion and stay relevant in your field!

In a Competitive Digital-First Live Events Landscape, Modernization Is the Key to Staying Relevant, Says Info-Tech Research Group

Retrieved on: 
Wednesday, May 3, 2023
Problem solving, Failure, COVID-19, OTT, Research, Mitigation, Frictionless, Amazon, Organization, Sport, Digital, Netflix, Create, Tourism, Risk management, Electric motor

This means venue modernization is critical to staying competitive and attracting a younger generation in today's digital experience economy.

Key Points: 
  • This means venue modernization is critical to staying competitive and attracting a younger generation in today's digital experience economy.
  • To support organizational leaders in their pursuit of venue modernization, Info-Tech Research Group has published its newest digital use case report, Modernize the Venue to Revitalize Live Events .
  • It is particularly important to remember that live events are competing not only with one another, but also with virtual events.
  • For more information about Info-Tech Research Group or to view the latest research, visit infotech.com and connect via LinkedIn and Twitter .

Annals of Family Medicine: Two Papers Describe How Developing Systems and Enhancing Education for Mifepristone Use Can Lead to Greater Abortion Medication Access

Retrieved on: 
Thursday, April 27, 2023
Learning, REMS, Annals of Family Medicine, Pregnancy, Family medicine, University, Expansion, Mitigation, ANN, Misoprostol, Pharmacy, Harvard Medical School, Mifepristone, Patient, University of Minnesota Medical School, Knowledge, Risk Evaluation and Mitigation Strategies, FDA, Community health, Safety, Birth control

Approved by the FDA in 2000, mifepristone is used, along with misoprostol, to end a pregnancy in the first 10 weeks of gestation and in miscarriage management.

Key Points: 
  • Approved by the FDA in 2000, mifepristone is used, along with misoprostol, to end a pregnancy in the first 10 weeks of gestation and in miscarriage management.
  • While misoprostol is readily available, mifepristone distribution has been restricted.
  • One clinical innovation that could increase access to the drug in the family medicine context includes streamlining prescription ordering processes.
  • Another intervention used in two Chicago-area federally qualified health centers, titled, "Excellence in Providing Access to New Directions in Mifepristone Use" (ExPAND Mifepristone), took a different approach to expanding access to the mifepristone.

Arkose Labs Adds Advanced Phishing Protection to Its Industry-Leading Bot Management Platform, Arkose Bot Manager

Retrieved on: 
Thursday, April 20, 2023
Cyberattack, MFA, CDN, Use, Arkose, Internet, URL, Ease, SMS, OTP, PIN, Proxy, FBI, Likelihood function, Minimisation, IC3, Mitigation, ROI, SDK, Economics, Arms industry, Cryptocurrency, Online shopping, G2

Arkose Bot Manager is the evolution of the industry-leading Arkose platform, with phishing protection, CDN integration, and recently announced email intelligence features.

Key Points: 
  • Arkose Bot Manager is the evolution of the industry-leading Arkose platform, with phishing protection, CDN integration, and recently announced email intelligence features.
  • Arkose Bot Manager is the only bot management solution backed by two separate $1 million warranties.
  • The Spring 2023 G2 Grid® Report for Bot Detection and Mitigation rated Arkose Labs with over 98 percent customer satisfaction in every category.
  • Arkose Bot Manager received the highest ratings among its competitors for Ease of Use, Ease of Setup, Ease of Admin, and Likelihood to Recommend.